Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Senn

Showing results (71-80 of 2,598) with videos related to

Pageof 260
Sort By:
Revue Medicale Suisse|July 4, 2024
Nicolas Senn
Statistics in Medicine|November 17, 2022
Conditions for success and margins of error: Estimation in clinical trialsStephen Senn
Medical Examiner (Chicago, Ill.)|August 9, 2023
Areolar Carcinoma of Omentum, Simulating Ovarian TumorN Senn
Medical Examiner (Chicago, Ill.)|August 9, 2023
An Essay on the Pathology and Treatment of CancerN Senn
Pharmaceutical Statistics|July 12, 2022
The design and analysis of vaccine trials for COVID-19 for the purpose of estimating efficacyStephen Senn
Revue Medicale Suisse|September 25, 2025
Nicolas Senn
Clinical Pharmacology and Therapeutics|July 9, 2010
Statisticians and pharmacokineticists: what they can still learn from each otherS Senn
Statistical Methods in Medical Research|September 9, 2017
Sample size considerations for n-of-1 trialsStephen Senn
BMJ (Clinical Research Ed.)|October 23, 2004
Individual response to treatment: is it a valid assumption?Stephen Senn
BMJ (Clinical Research Ed.)|December 14, 1996
Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandonedS Senn
Pageof 260

Showing results (71-80 of 2,598) with videos related to

Sort By:
Pageof 260
Revue Medicale Suisse|July 4, 2024
Nicolas Senn
Statistics in Medicine|November 17, 2022
Conditions for success and margins of error: Estimation in clinical trialsStephen Senn
Medical Examiner (Chicago, Ill.)|August 9, 2023
Areolar Carcinoma of Omentum, Simulating Ovarian TumorN Senn
Medical Examiner (Chicago, Ill.)|August 9, 2023
An Essay on the Pathology and Treatment of CancerN Senn
Pharmaceutical Statistics|July 12, 2022
The design and analysis of vaccine trials for COVID-19 for the purpose of estimating efficacyStephen Senn
Revue Medicale Suisse|September 25, 2025
Nicolas Senn
Clinical Pharmacology and Therapeutics|July 9, 2010
Statisticians and pharmacokineticists: what they can still learn from each otherS Senn
Statistical Methods in Medical Research|September 9, 2017
Sample size considerations for n-of-1 trialsStephen Senn
BMJ (Clinical Research Ed.)|October 23, 2004
Individual response to treatment: is it a valid assumption?Stephen Senn
BMJ (Clinical Research Ed.)|December 14, 1996
Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandonedS Senn
Pageof 260